Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$20.09 - $35.8 $359,611 - $640,820
17,900 New
17,900 $0
Q1 2022

May 16, 2022

SELL
$36.48 - $52.22 $652,992 - $934,738
-17,900 Reduced 37.61%
29,700 $1,000
Q3 2021

Nov 12, 2021

BUY
$50.07 - $66.05 $90,126 - $118,890
1,800 Added 3.93%
47,600 $2,000
Q1 2021

May 17, 2021

BUY
$86.23 - $125.19 $3.95 Million - $5.73 Million
45,800 New
45,800 $4,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $427M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.